{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T14:01:35Z","timestamp":1790085695569,"version":"4.0.1"},"reference-count":37,"publisher":"BMJ","issue":"5","license":[{"start":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T00:00:00Z","timestamp":1779062400000},"content-version":"unspecified","delay-in-days":17,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Chipscreen Biosciences","award":["CGZIIT-113"],"award-info":[{"award-number":["CGZIIT-113"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2026,4,30]]},"published-print":{"date-parts":[[2026,5]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Metabolic dysfunction-associated steatohepatitis (MASH), formerly known as non-alcoholic steatohepatitis (NASH), is the hepatic manifestation of the metabolic syndrome. When it co-occurs with type 2 diabetes (T2DM), it presents a significant therapeutic challenge due to a higher risk of fibrosis progression and adverse outcomes. While new treatments for MASH are emerging, their efficacy in the T2DM subpopulation remains an unmet need. Chiglitazar is a novel peroxisome proliferator-activated receptor pan-agonist that regulates key pathways in lipid metabolism, glucose homeostasis and inflammation. This trial aims to evaluate the efficacy and safety of chiglitazar as a combination therapy for patients with MASH and T2DM.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and analysis<\/jats:title>\n                    <jats:p>This is a prospective, multicentre, randomised, double-blind, placebo-controlled study. This trial will enrol 300 adult patients aged 18\u201375 years with biopsy-confirmed MASH and fibrosis stage F1 or higher. Participants will be randomised (1:1) to receive either chiglitazar 48\u2009mg daily or a matching placebo. All participants will also receive background therapy consisting of vitamin E (100\u2009mg three times a day) and polyene phosphatidyl choline (456\u2009mg three times a day). The treatment duration is 78 weeks. The primary efficacy endpoint is resolution of steatohepatitis with no worsening of liver fibrosis. Key secondary endpoints include improvement in liver fibrosis by at least one stage and changes in metabolic and liver safety biomarkers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics and dissemination<\/jats:title>\n                    <jats:p>Ethical approval has been obtained from the Shanghai Punan Hospital of Pudong New District Ethics Committee (Punan Branch of Renji Hospital Ethics Committee, Shanghai Jiaotong University School of Medicine). KY2025-066. The findings will be disseminated through publication in peer-reviewed journals and presentations at scientific conferences.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" xlink:href=\"NCT07303803\">NCT07303803<\/jats:ext-link>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2026-116945","type":"journal-article","created":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T14:50:44Z","timestamp":1779115844000},"page":"e116945","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["Chiglitazar in combination with anti-inflammatory and hepatoprotective therapy for the treatment of MASH associated with T2DM: a prospective, multicentre, randomised, double-blind, placebo-controlled study protocol"],"prefix":"10.1136","volume":"16","clinical-trial-number":[{"clinical-trial-number":"nct07303803","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct07303803","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-0572-2053","authenticated-orcid":false,"given":"Kai","family":"He","sequence":"first","affiliation":[{"name":"Department of Gastroenterology, Ren Ji Hospital, Punan Campus, School of Medicine, Shanghai Jiao Tong University, Shanghai, China"},{"name":"Department of Gastroenterology, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China"},{"name":"Shanghai Institute of Digestive Disease, Key Laboratory of Gastroenterology and Hepatology, Chinese Ministry of Health (Shanghai Jiao Tong University), Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengyuan","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Ren Ji Hospital, Punan Campus, School of Medicine, Shanghai Jiao Tong University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Shao","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Ren Ji Hospital, Punan Campus, School of Medicine, Shanghai Jiao Tong University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanjun","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Ultrasound, Ren Ji Hospital, Punan Campus, School of Medicine, Shanghai Jiao Tong University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyi","family":"Gu","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China"},{"name":"Shanghai Institute of Digestive Disease, Key Laboratory of Gastroenterology and Hepatology, Chinese Ministry of Health (Shanghai Jiao Tong University), Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeyu","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Ren Ji Hospital, Punan Campus, School of Medicine, Shanghai Jiao Tong University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunxia","family":"Gan","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Ren Ji Hospital, Punan Campus, School of Medicine, Shanghai Jiao Tong University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Ren Ji Hospital, Punan Campus, School of Medicine, Shanghai Jiao Tong University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Ren Ji Hospital, Punan Campus, School of Medicine, Shanghai Jiao Tong University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunxin","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Ultrasound, Ren Ji Hospital, Punan Campus, School of Medicine, Shanghai Jiao Tong University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bei","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Ultrasound, Ren Ji Hospital, Punan Campus, School of Medicine, Shanghai Jiao Tong University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3526-6488","authenticated-orcid":false,"given":"Lingling","family":"Gao","sequence":"additional","affiliation":[{"name":"Clinical Research Institute, Institute of Advanced Clinical Medicine, Peking University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan","family":"Yan","sequence":"additional","affiliation":[{"name":"Clinical Research Institute, Institute of Advanced Clinical Medicine, Peking University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Yao","sequence":"additional","affiliation":[{"name":"Clinical Research Institute, Institute of Advanced Clinical Medicine, Peking University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaoyun","family":"Shen","sequence":"additional","affiliation":[{"name":"Shenzhen Chipscreen Biosciences Co., Ltd, Shenzhen, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peixuan","family":"Ji","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China"},{"name":"Shanghai Institute of Digestive Disease, Key Laboratory of Gastroenterology and Hepatology, Chinese Ministry of Health (Shanghai Jiao Tong University), Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianyi","family":"Wei","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China"},{"name":"Shanghai Institute of Digestive Disease, Key Laboratory of Gastroenterology and Hepatology, Chinese Ministry of Health (Shanghai Jiao Tong University), Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuexiang","family":"Bian","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China"},{"name":"Shanghai Institute of Digestive Disease, Key Laboratory of Gastroenterology and Hepatology, Chinese Ministry of Health (Shanghai Jiao Tong University), Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yawen","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China"},{"name":"Shanghai Institute of Digestive Disease, Key Laboratory of Gastroenterology and Hepatology, Chinese Ministry of Health (Shanghai Jiao Tong University), Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adila","family":"Abuduaini","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China"},{"name":"Shanghai Institute of Digestive Disease, Key Laboratory of Gastroenterology and Hepatology, Chinese Ministry of Health (Shanghai Jiao Tong University), Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianyong","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Ren Ji Hospital, Punan Campus, School of Medicine, Shanghai Jiao Tong University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Ren Ji Hospital, Punan Campus, School of Medicine, Shanghai Jiao Tong University, Shanghai, China"},{"name":"Department of Gastroenterology, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China"},{"name":"Shanghai Institute of Digestive Disease, Key Laboratory of Gastroenterology and Hepatology, Chinese Ministry of Health (Shanghai Jiao Tong University), Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,5,18]]},"reference":[{"key":"2026060801251507000_16.5.e116945.1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2019.11.312"},{"key":"2026060801251507000_16.5.e116945.2","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-019-00960-3"},{"key":"2026060801251507000_16.5.e116945.3","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S2468-1253(22)00165-0","article-title":"The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis","volume":"7","author":"Riazi","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2026060801251507000_16.5.e116945.4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2019.06.021"},{"key":"2026060801251507000_16.5.e116945.5","doi-asserted-by":"crossref","DOI":"10.3390\/ijms242015473","article-title":"Metabolic-Dysfunction-Associated Steatotic Liver Disease-Its Pathophysiology, Association with Atherosclerosis and Cardiovascular Disease, and Treatments","volume":"24","author":"Yanai","year":"2023","journal-title":"Int J Mol Sci"},{"key":"2026060801251507000_16.5.e116945.6","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2023.04.025"},{"key":"2026060801251507000_16.5.e116945.7","article-title":"NAFLD Fibrosis Progression and Type 2 Diabetes: The Hepatic-Metabolic Interplay","volume":"14","author":"Cernea","year":"2024","journal-title":"Life (Basel)"},{"key":"2026060801251507000_16.5.e116945.8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2413258"},{"key":"2026060801251507000_16.5.e116945.9","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-020-00366-5"},{"key":"2026060801251507000_16.5.e116945.10","doi-asserted-by":"publisher","DOI":"10.1038\/nrm3198"},{"key":"2026060801251507000_16.5.e116945.11","doi-asserted-by":"crossref","first-page":"111688","DOI":"10.1016\/j.diabres.2024.111688","article-title":"MASLD\/MASH and type 2 diabetes: Two sides of the same coin? From single PPAR to pan-PPAR agonists","volume":"212","author":"Cooreman","year":"2024","journal-title":"Diabetes Res Clin Pract"},{"key":"2026060801251507000_16.5.e116945.12","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbalip.2007.02.013"},{"key":"2026060801251507000_16.5.e116945.13","doi-asserted-by":"crossref","first-page":"108391","DOI":"10.1016\/j.pharmthera.2023.108391","article-title":"PPAR-\u03b3 signaling in nonalcoholic fatty liver disease: Pathogenesis and therapeutic targets","volume":"12","author":"Chen","year":"2023","journal-title":"Pharmacol Ther"},{"key":"2026060801251507000_16.5.e116945.14","first-page":"87","article-title":"Chiglitazar: First Approval","volume":"82","author":"Deeks","year":"2022","journal-title":"Drugs (Abingdon Engl)"},{"key":"2026060801251507000_16.5.e116945.15","first-page":"1571","article-title":"Efficacy and safety of chiglitazar, a novel peroxisome proliferator-activated receptor pan-agonist, in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled, phase 3 trial (CMAP)","volume":"66","author":"Ji","year":"2021","journal-title":"Sci Bull Sci Found Philipp"},{"key":"2026060801251507000_16.5.e116945.16","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1016\/j.scib.2021.02.027","article-title":"Chiglitazar monotherapy with sitagliptin as an active comparator in patients with type 2 diabetes: a randomized, double-blind, phase 3 trial (CMAS)","volume":"66","author":"Jia","year":"2021","journal-title":"Sci Bull (Beijing)"},{"key":"2026060801251507000_16.5.e116945.17","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1097\/HEP.0000000000001475","article-title":"Chiglitazar in MASLD with hypertriglyceridemia and insulin resistance: A phase II, randomized, double-blind, placebo-controlled study","volume":"83","author":"Sun","year":"2026","journal-title":"Hepatology"},{"key":"2026060801251507000_16.5.e116945.18","doi-asserted-by":"crossref","DOI":"10.1016\/j.xcrm.2025.101939","article-title":"Vitamin E (300 mg) in the treatment of MASH: A multi-center, randomized, double-blind, placebo-controlled study","volume":"6","author":"Song","year":"2025","journal-title":"Cell Rep Med"},{"key":"2026060801251507000_16.5.e116945.19","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2022.810143","article-title":"Polyene Phosphatidylcholine Ameliorates High Fat Diet-Induced Non-alcoholic Fatty Liver Disease via Remodeling Metabolism and Inflammation","volume":"13","author":"Lu","year":"2022","journal-title":"Front Physiol"},{"key":"2026060801251507000_16.5.e116945.20","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21113863","article-title":"The Role of Insulin Resistance and Diabetes in Nonalcoholic Fatty Liver Disease","volume":"21","author":"Fujii","year":"2020","journal-title":"Int J Mol Sci"},{"key":"2026060801251507000_16.5.e116945.21","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2006-0587"},{"key":"2026060801251507000_16.5.e116945.22","doi-asserted-by":"crossref","DOI":"10.1186\/s12916-019-1321-x","article-title":"Risks and clinical predictors of cirrhosis and hepatocellular carcinoma diagnoses in adults with diagnosed NAFLD: real-world study of 18 million patients in four European cohorts","volume":"17","author":"Alexander","year":"2019","journal-title":"BMC Med"},{"key":"2026060801251507000_16.5.e116945.23","doi-asserted-by":"publisher","DOI":"10.1002\/hep.28431"},{"key":"2026060801251507000_16.5.e116945.24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2017.07.027"},{"key":"2026060801251507000_16.5.e116945.25","first-page":"729","article-title":"Resmetirom: First Approval","volume":"84","author":"Keam","year":"2024","journal-title":"Drugs (Abingdon Engl)"},{"key":"2026060801251507000_16.5.e116945.26","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2309000"},{"key":"2026060801251507000_16.5.e116945.27","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1159\/000539371","article-title":"EASL-EASD-EASO Clinical Practice Guidelines on the Management of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)","volume":"17","year":"2024","journal-title":"Obes Facts"},{"key":"2026060801251507000_16.5.e116945.28","unstructured":"Alkhouri N . Phase 3 ESSENCE Trial: Semaglutide in Metabolic Dysfunction-Associated Steatohepatitis. Gastroenterol Hepatol (Bartlesville) 2024;20."},{"key":"2026060801251507000_16.5.e116945.29","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.241410198"},{"key":"2026060801251507000_16.5.e116945.30","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.274.45.32048"},{"key":"2026060801251507000_16.5.e116945.31","doi-asserted-by":"publisher","DOI":"10.1152\/physiolgenomics.00127.2009"},{"key":"2026060801251507000_16.5.e116945.32","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.00391.2009"},{"key":"2026060801251507000_16.5.e116945.33","doi-asserted-by":"publisher","DOI":"10.2174\/09298673113209990136"},{"key":"2026060801251507000_16.5.e116945.34","doi-asserted-by":"publisher","DOI":"10.14218\/jcth.2022.00067"},{"key":"2026060801251507000_16.5.e116945.35","first-page":"2325","article-title":"The effect of polyene phosphatidyl choline intervention on nonalcoholic steatohepatitis and related mechanism","volume":"8","author":"Cao","year":"2016","journal-title":"Am J Transl Res"},{"key":"2026060801251507000_16.5.e116945.36","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgast-2019-000341","article-title":"Effectiveness of phosphatidylcholine in alleviating steatosis in patients with non-alcoholic fatty liver disease and cardiometabolic comorbidities (MANPOWER study)","volume":"7","author":"Maev","year":"2020","journal-title":"BMJ Open Gastroenterol"},{"key":"2026060801251507000_16.5.e116945.37","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1097\/HEP.0000000000000913","article-title":"Epidemiology, screening, and co-management of type 2 diabetes mellitus and metabolic dysfunction-associated steatotic liver disease","volume":"83","author":"Qi","year":"2026","journal-title":"Hepatology"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2026-116945","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T08:26:03Z","timestamp":1780907163000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2026-116945"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":37,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,5,18]]},"published-print":{"date-parts":[[2026,5]]}},"alternative-id":["10.1136\/bmjopen-2026-116945"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2026-116945","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5]]}}}